Malaria Research Capacity Development in West and Central Africa Consortium Report issue

Foundation Phase 4

Organization Overview

First Clinical Trial
2019
NCT04565184
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Malaria Research Capacity Development in West and Central Africa Consortium

Active Ingredients

Drugs in Phase 4 Trials (4)

amodiaquine (camoquin) (1 trial)

artemether (1 trial)

artesunate (1 trial)

lumefantrine (Coartem) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malaria (Phase 4)

Malaria, Falciparum (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 4